In addition, ProQR Therapeutics (PRQR) sold 3.52M shares of common stock to existing shareholder Eli Lilly (LLY). Evercore ISI, Cantor Fitzgerald, Raymond James and Oppenheimer acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRQR: